Dynamics of Matricellular Protein Levels in Blood Predict Recovery in Patients with Human Immunodeficiency Virus-Tuberculosis Coinfection

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2024 May 25

PMID 38793546

Authors

Ashwini Shete

Manisha Ghate

Hiroko Iwasaki-Hozumi

Sandip Patil

Pallavi Shidhaye

Gaowa Bai

Takashi Matsuba

Pratiksha Pharande

Bharati Mahajan

Aarti Randive

Anupam Mukherjee

Toshio Hattori

Affiliations

Soon will be listed here.

Abstract

Chronic immune activation in tuberculosis (TB) associated with human immunodeficiency virus (HIV) infection (HIV/TB) modifies their clinical course. We prospectively measured osteopontin (OPN), full-length galectin-9 (FL-Gal9), and total-Gal9 (T-Gal9) levels in 32 patients with HIV/TB coinfection treated with anti-tuberculosis and antiretroviral therapies over 6-18 months to determine the amelioration of inflammatory conditions in response to the therapies. We observed a significant time-dependent decrease in FL-Gal9 in both pulmonary TB (PTB, n = 20) and extrapulmonary TB (EPTB, n = 12) patients. The levels of T-Gal9, OPN, and CRP decreased significantly after treatment in only PTB patients. We calculated the inflammatory score (INS) indicating immunologic recovery based on the decline in OPN, FL-Gal9, T-Gal9, and CRP levels. Baseline levels of T-Gal9 and OPN positively correlated with INS in all TB and only PTB patients, respectively, indicating that their levels predict better recovery. In contrast, FL-Gal9 levels at the second visit negatively correlated with INS in EPTB patients. The decrease rate in OPN levels at the second visit also correlated positively with INS in PTB patients. Women showed a higher INS and lower levels of FL-Gal9 than men. The patients with moderate grade severity on chest X-ray had higher CD4 cell numbers than those with limited grade severity. Monitoring these markers will help to predict and assess the response to therapy as well as to devise strategies to reduce the complications caused by chronic immune activation in patients with HIV/TB coinfection.

Citing Articles

and HIV Co-Infection: A Public Health Problem That Requires Ongoing Attention.

Shen Y Viruses. 2024; 16(9).

PMID: 39339850 PMC: 11435851. DOI: 10.3390/v16091375.

References

Nagahara K, Arikawa T, Oomizu S, Kontani K, Nobumoto A, Tateno H . Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions. J Immunol. 2008; 181(11):7660-9. PMC: 5886706. DOI: 10.4049/jimmunol.181.11.7660. View

Chaisson R, Clermont H, Holt E, Cantave M, Johnson M, Atkinson J . Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection. Am J Respir Crit Care Med. 1996; 154(4 Pt 1):1034-8. DOI: 10.1164/ajrccm.154.4.8887603. View

Smith R, Yew K, Berkowitz K, Aranda C . Factors affecting the yield of acid-fast sputum smears in patients with HIV and tuberculosis. Chest. 1994; 106(3):684-6. DOI: 10.1378/chest.106.3.684. View

Gupta A, Wood R, Kaplan R, Bekker L, Lawn S . Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PLoS One. 2012; 7(3):e34156. PMC: 3316623. DOI: 10.1371/journal.pone.0034156. View

Niki T, Fujita K, Rosen H, Hirashima M, Masaki T, Hattori T . Plasma Galectin-9 Concentrations in Normal and Diseased Condition. Cell Physiol Biochem. 2018; 50(5):1856-1868. DOI: 10.1159/000494866. View

Dravid A, Natarajan K, Medisetty M, Gawali R, Mahajan U, Kulkarni M . Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India. BMC Infect Dis. 2019; 19(1):714. PMC: 6692924. DOI: 10.1186/s12879-019-4361-0. View

Rahmati A, Bigam S, Elahi S . Galectin-9 promotes natural killer cells activity interaction with CD44. Front Immunol. 2023; 14:1131379. PMC: 10060867. DOI: 10.3389/fimmu.2023.1131379. View

Kon S, Nakayama Y, Matsumoto N, Ito K, Kanayama M, Kimura C . A novel cryptic binding motif, LRSKSRSFQVSDEQY, in the C-terminal fragment of MMP-3/7-cleaved osteopontin as a novel ligand for α9β1 integrin is involved in the anti-type II collagen antibody-induced arthritis. PLoS One. 2014; 9(12):e116210. PMC: 4278882. DOI: 10.1371/journal.pone.0116210. View

Wang D, Tong X, Wang L, Zhang S, Huang J, Zhang L . The association between osteopontin and tuberculosis: A systematic review and meta-analysis. PLoS One. 2020; 15(12):e0242702. PMC: 7710079. DOI: 10.1371/journal.pone.0242702. View

10.

Hernandez-Bazan S, Mata-Espinosa D, Lozano-Ordaz V, Ramos-Espinosa O, Barrios-Payan J, Lopez-Casillas F . Immune Regulatory Effect of Osteopontin Gene Therapy in a Murine Model of Multidrug Resistant Pulmonary Tuberculosis. Hum Gene Ther. 2022; 33(19-20):1037-1051. DOI: 10.1089/hum.2022.030. View

11.

Suthar A, Lawn S, Del Amo J, Getahun H, Dye C, Sculier D . Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med. 2012; 9(7):e1001270. PMC: 3404110. DOI: 10.1371/journal.pmed.1001270. View

12.

Kumar P . Adult pulmonary tuberculosis as a pathological manifestation of hyperactive antimycobacterial immune response. Clin Transl Med. 2016; 5(1):38. PMC: 5052244. DOI: 10.1186/s40169-016-0119-0. View

13.

Nau G, Guilfoile P, Chupp G, Berman J, Kim S, Kornfeld H . A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. Proc Natl Acad Sci U S A. 1997; 94(12):6414-9. PMC: 21064. DOI: 10.1073/pnas.94.12.6414. View

14.

Iwasaki-Hozumi H, Chagan-Yasutan H, Ashino Y, Hattori T . Blood Levels of Galectin-9, an Immuno-Regulating Molecule, Reflect the Severity for the Acute and Chronic Infectious Diseases. Biomolecules. 2021; 11(3). PMC: 7998537. DOI: 10.3390/biom11030430. View

15.

Darboe F, Mbandi S, Naidoo K, Yende-Zuma N, Lewis L, Thompson E . Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral Therapy. Front Microbiol. 2019; 10:1441. PMC: 6608601. DOI: 10.3389/fmicb.2019.01441. View

16.

Shiratori B, Leano S, Nakajima C, Chagan-Yasutan H, Niki T, Ashino Y . Elevated OPN, IP-10, and neutrophilia in loop-mediated isothermal amplification confirmed tuberculosis patients. Mediators Inflamm. 2014; 2014:513263. PMC: 4213984. DOI: 10.1155/2014/513263. View

17.

Shete A, Bichare S, Pujari V, Virkar R, Thakar M, Ghate M . Elevated Levels of Galectin-9 but Not Osteopontin in HIV and Tuberculosis Infections Indicate Their Roles in Detecting MTB Infection in HIV Infected Individuals. Front Microbiol. 2020; 11:1685. PMC: 7380070. DOI: 10.3389/fmicb.2020.01685. View

18.

Perriens J, St Louis M, Mukadi Y, Brown C, Prignot J, Pouthier F . Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. N Engl J Med. 1995; 332(12):779-84. DOI: 10.1056/NEJM199503233321204. View

19.

Rodriguez-Takeuchi S, Renjifo M, Medina F . Extrapulmonary Tuberculosis: Pathophysiology and Imaging Findings. Radiographics. 2019; 39(7):2023-2037. DOI: 10.1148/rg.2019190109. View

20.

Sun J, Sui Y, Wang Y, Song L, Li D, Li G . Galectin-9 expression correlates with therapeutic effect in rheumatoid arthritis. Sci Rep. 2021; 11(1):5562. PMC: 7946964. DOI: 10.1038/s41598-021-85152-2. View